1alpha-Hydroxyvitamin D5

含有 1alpha-Hydroxyvitamin D5 的品牌、食物注意事项以及最重要的药物相互作用。

品牌

未找到该活性成分的已注册品牌。

食物注意事项

该活性成分暂无已收录的食物注意事项。

最重要的相互作用

前 10 项，共 50 项

Acetyldigoxin中等
当 1alpha-Hydroxyvitamin D5 与 Acetyldigoxin 联合使用时，发生室性心律失常 ve 心律失常的风险或严重程度可能增加。
专业视图
The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha-Hydroxyvitamin D5 is combined with Acetyldigoxin.
Buthiazide中等
当 Buthiazide 与 1alpha-Hydroxyvitamin D5 联合使用时，发生高钙血症的风险或严重程度可能增加。
专业视图
The risk or severity of hypercalcemia can be increased when Buthiazide is combined with 1alpha-Hydroxyvitamin D5.
Calcium cation中等
当 1alpha-Hydroxyvitamin D5 与 Calcium cation 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium cation.
Calcium glubionate anhydrous中等
当 1alpha-Hydroxyvitamin D5 与 Calcium glubionate anhydrous 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium glubionate anhydrous.
Calcium lactate中等
当 1alpha-Hydroxyvitamin D5 与 Calcium lactate 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium lactate.
Calcium lactate gluconate中等
当 1alpha-Hydroxyvitamin D5 与 Calcium lactate gluconate 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium lactate gluconate.
Calcium levulinate中等
当 1alpha-Hydroxyvitamin D5 与 Calcium levulinate 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium levulinate.
Calcium pangamate中等
当 1alpha-Hydroxyvitamin D5 与 Calcium pangamate 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium pangamate.
Calcium polycarbophil中等
当 1alpha-Hydroxyvitamin D5 与 Calcium polycarbophil 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium polycarbophil.
Cyclopenthiazide中等
当 Cyclopenthiazide 与 1alpha-Hydroxyvitamin D5 联合使用时，发生高钙血症的风险或严重程度可能增加。
专业视图
The risk or severity of hypercalcemia can be increased when Cyclopenthiazide is combined with 1alpha-Hydroxyvitamin D5.